New Releases from NCBI BookshelfDupilumab (Dupixent): Indication: For the treatment of adult patients with moderate-to-severe prurigo nodularis (PN) whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. Dupixent can be used with or without topical corticosteroids: Reimbursement Recommendation [Internet].​Dupilumab (Dupixent): Indication: For the treatment of adult patients with moderate-to-severe prurigo nodularis (PN) whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. Dupixent can be used with or without topical corticosteroids: Reimbursement Recommendation [Internet].